HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thrombopoietin receptor (Mpl) expression by megakaryocytes in myeloproliferative disorders.

Abstract
The thrombopoietin receptor (Mpl) is involved in the pathogenesis of chronic myeloproliferative disorders (CMPD). In this study, we determined Mpl expression by bone marrow cells and megakaryocytes in CMPD by applying laser microdissection, real-time RT-PCR, and immunohistochemistry. Mpl mRNA expression was significantly increased up to 9-fold in total bone marrow cells (p < 0.001) and up to 4-fold in megakaryocytes in chronic myeloproliferative disorders (n = 73) compared to normal controls (n = 26, p = 0.01). Immunohistochemistry revealed heterogeneous Mpl expression by megakaryocytes in CMPD with a stronger accentuation in idiopathic myelofibrosis (IMF) in comparison to polycythaemia vera (PV) and essential thrombocythemia (ET). In addition to megakaryocytes, the erythropoietic lineage was prominently labelled by Mpl antiserum, with considerably stronger staining in polycythaemia vera. We conclude that, in CMPD, megakaryocytes and erythroid cells exhibit increased Mpl expression levels which may contribute to the sustained proliferation of both cell lineages in CMPD.
AuthorsOliver Bock, Jerome Schlué, Michael Mengel, Guntram Büsche, Ebru Serinsöz, Hans Kreipe
JournalThe Journal of pathology (J Pathol) Vol. 203 Issue 1 Pg. 609-15 (May 2004) ISSN: 0022-3417 [Print] England
PMID15095485 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Chemical References
  • Neoplasm Proteins
  • Proto-Oncogene Proteins
  • RNA, Messenger
  • Receptors, Cytokine
  • Receptors, Thrombopoietin
  • MPL protein, human
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Bone Marrow Cells (metabolism)
  • Chronic Disease
  • Erythroid Cells (metabolism)
  • Female
  • Gene Expression (physiology)
  • Humans
  • Immunohistochemistry (methods)
  • Laser Therapy (methods)
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive (metabolism)
  • Male
  • Megakaryocytes (metabolism)
  • Middle Aged
  • Myeloproliferative Disorders (metabolism)
  • Neoplasm Proteins (analysis)
  • Polycythemia Vera (metabolism)
  • Primary Myelofibrosis (metabolism)
  • Proto-Oncogene Proteins (analysis)
  • RNA, Messenger (analysis)
  • Receptors, Cytokine (analysis)
  • Receptors, Thrombopoietin
  • Reverse Transcriptase Polymerase Chain Reaction (methods)
  • Thrombocythemia, Essential (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: